글로벌 생물학적 치료 시장 – 2029년까지의 산업 동향 및 예측

생물학적 치료 시장 분석 및 규모

글로벌 생물학적 치료 시장은 예측 기간 동안 상당한 성장을 목격할 것으로 예상됩니다. 전 세계 생물학적 치료 시장은 앞으로 몇 년 동안 크게 상승할 것으로 예상됩니다. 이 치료법은 근본적으로 신체 시스템을 직접적으로 또는 암과 싸우기 위해 사용합니다. 암 생물학적 치료 시장의 수많은 전문가들은 나노기술을 활용하여 환자에게 개발 치료법을 제공하는 데 주력하고 있습니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 생물학적 치료 시장의 성장률을 분석합니다. 글로벌 생물학적 치료 시장의 예상 CAGR은 언급된 예측 기간 동안 약 9.32%인 경향이 있습니다. 이 시장은 2021년에 3,502억 1,000만 달러로 평가되었으며 2029년까지 7,143억 7,000만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

생물학적 치료는 건강한 세포에 영향을 미치지 않고 암세포와 싸우기 위해 신체의 면역 체계를 사용하는 암 치료법입니다. 단일클론 항체와 같은 생물학적 약물 치료는 암 성장을 방해하거나 세포 사멸을 증가시킴으로써 작용을 발휘합니다. 다양한 유형의 생물학적 치료에는 인터페론, 단일클론 항체, 인터루킨 및 백신이 있습니다 . 이는 의료 분야에 매우 중요하므로 예측 기간 동안 크게 상승할 것으로 예상됩니다.

생물학적 치료 시장 범위 및 세분화

Global Biological Therapy Market Dynamics

Drivers

• Increase in Cancer Cases

The rise in cancer cases globally boosts the global cancer biological therapy market in the forecast period As per the reports of the American Cancer Society Statistics in 2016, majority of cases of SCLC mostly occur in individuals between the age group of 60-80 years with an estimated global death rate being 30,000 per year. In addition to this, as per the reports of WHO, lung cancer is the second most dominant cancer in men and women causing 1.59 million deaths in 2012. This boost the market growth.

• Advancements in Biomedical Science

Biological drugs result from innovative research and allow for the most recent scientific breakthroughs, which can lead to novel medicines that offer patients several new treatment options. Additionally, better knowledge on the genetic and molecular level has paved the way for several advanced treatments. For instance, recombinant proteins help the immune system identify and bind foreign molecules. Biologics are estimated to grow promptly in the next years due to the high productivity of small molecule therapeutics. Major market players in the pharmaceutical industry are continuously focusing on developing innovative drugs to keep up with the competition.

Opportunities

• Rising Cases of Chronic Diseases

Continuous advances in biotechnology and biomedical science techniques have significantly enhanced the process of developing biologics for treating various chronic illnesses. Products range from simple monoclonal antibodies to targeted pharmaceuticals such as antibody-drug conjugates, radio immunotherapies, and bispecific antibodies that can target multiple locations simultaneously. Thus, all these factors create many opportunities for market growth as the need for biological therapy increases.

• Growing Relevance of Biological Therapy with Other Diseases

Biological treatments are becoming more important in a rising variety of illness categories. These firms will be looking for ways to increase their disease-area leadership by investing more in biologic medicines and biotech capabilities. For instance, AstraZeneca, one of the top leading firms in the respiratory sector is all set to join the respiratory biologics market with its new drug, benralizumab. This is anticipated to provide new hope to cancer patients.

Restraints/Challenges

• Lack of Authorized Support

Lack of support from recognized authorizations could limit the growth of the global biological therapy market over a forecast period. Several medical insurance companies in numerous developing countries such as India do not cover biological therapy and there is not much government support. This hampers the market growth.

• Increasing Cost Of Treatments

The huge expenditure required for the treatment methods surely hamper the market growth. Many of the treatments involved in this disease require high cost and thus at times gets difficult for many people, especially the ones in the rural areas. Thus, this can act as a major hindrance factor for the market.

This global biological therapy market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global biological therapy market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Biological Therapy Market

The COVID-19 pandemic has had a significant detrimental influence on the global biological therapy market. The supply chain of biologics was disturbed because of the COVID-19 outbreak and lockdown. Hospitals and clinics are predominantly reserved for severe and critical COVID-19 patients. Researchers faced hurdles associated with different other diseases. The demand for several vaccinations and other preventative majors increased dramatically as a result of COVID-19. Since these vaccines were dominating the market, the impact of COVID-19 on the biologics market was minimal. However, in the post-pandemic era, the market showed a high rise and is expected to rise high in the upcoming years.

Recent Developments

• In Feb 2021, GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration to jointly develop next-generation mRNA vaccines for COVID-19 with the utmost potential and aim to develop and address several evolving variants in a single vaccine.
• In April 2021, BMS announced its plans to build a new manufacturing site for the cell therapy division in the Netherlands.

Global Biological Therapy Market Scope

The global biological therapy market  is segmented on the basis of type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Monoclonal Antibodies
•  Naked monoclonal antibodies
• Conjugated monoclonal antibodies
• Bispecific monoclonal antibodies
• Vaccines
• Preventive vaccines
• Therapeutic vaccines
• Cancer Growth Blockers
• Tyrosine kinase inhibitors
• Proteasome inhibitors
• mTOR inhibitors
• Cytokine
• Interferons
• Interleukins
• Others

Route of Administration

• Intravenous
• Subcutaneous
• Intramuscular
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cancer Biological Therapy Market Regional Analysis/Insights

The global biological therapy market  is analysed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global biological therapy market  are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to have the highest market growth due to the increase prevalence of cancer, high demand of biological therapies and advanced healthcare facilities.

North America dominates the market due to the increase awareness about the diseases and rapidly disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cancer Biological Therapy Market Share Analysis

글로벌 생물학적 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 생물학적 치료 시장과 관련된 회사의 초점에만 관련이 있습니다. 

글로벌 생물학적 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd.(이스라엘)
• 사노피(프랑스)
• 파이저 주식회사(미국)
• GSK plc (영국)
• 노바티스 AG(스위스)
• Bayer AG(독일)
• 릴리(미국)
• 머크앤코(미국)
• Sun Pharmaceutical Industries Ltd. (인도)
• Aurobindo Pharma(인도)
• 루팡(인도)
• 엔도 파마슈티컬스 주식회사(아일랜드)
• Zydus 그룹(인도)
• Bausch Health Companies Inc. (캐나다)

SKU-54324